Home

NVS

Finding Value And Defense In Big Pharma Stocks

By Margin of Safety on Fri, 2011-12-23 22:07
(via seekingalpha.com)

ong brand names, patent protection, regulatory approvals, and economies of scale are all key factors in the development and sustainability of a competitive advantage in the drug industry.

Par Pharmaceuticals - Buried in the Generic Drugs Battlefield

By MagicDiligence on Thu, 2011-05-12 08:49
(via www.magicdiligence.com)

Par Pharmaceuticals is one of the smaller soldiers in the highly competitive generic drugs industry. Despite an excellent industry outlook, it will be an uphill battle for Par to generate outsized economic returns.

Advertisement:

The best dividend payers

By Margin of Safet... on Wed, 2010-12-15 10:29
(via marginofsafetyinvesting.com)

Searching for the best dividend stocks in the US...starting with the entire US listed stock universe and filtering down to 18 companies that have good dividends, business performance and conservative balance sheet and valuation

10 investment candidates...or close to

By Margin of Safet... on Tue, 2010-12-07 10:22
(via marginofsafetyinvesting.com)

Stocks that are close to or below a price at which they would deserve a closer look for a potential investment

The Forbes Top 150 Companies Ranked in Magic Formula Fashion

By MagicDiligence on Wed, 2010-05-19 06:46
(via www.magicdiligence.com)

The Forbes Top 150 Companies list ranked by Magic Formula Statistics. Which large global companies are both cheap and highly efficient with capital?

Magic Formula Stock Review: Impax Labratories (IPXL)

By MagicDiligence on Thu, 2010-05-13 08:35
(via www.magicdiligence.com)

Impax Pharmaceuticals is a generic drug maker. While the company is a "Magic Formula mirage" due to the 8-week generic Flomax exclusivity period, it still is an attractive Magic Formula stock for a variety of reasons.